Hepatitis C--knowledge & practices among the family physicians

A Sood1, V Midha, G Awasthi

  • 1Department of Medicine, Dayanand Medical College & Hospital, Ludhiana. ajitsood10@sify.com

Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation
|July 2, 2003
PubMed

Insights

Many family physicians in Punjab lack comprehensive knowledge about Hepatitis C virus (HCV) infection, including its diagnosis and management. Despite awareness of parenteral transmission, some continue unsafe practices like needle reuse, highlighting a need for increased physician education on HCV.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) is a significant global cause of end-stage liver disease.
  • Family physicians are often the first point of contact for patients with potential HCV infections.
  • Existing literature on HCV is extensive, but physician knowledge gaps persist.

Purpose of the Study:

  • To evaluate the existing knowledge of Hepatitis C virus (HCV) among practicing family physicians in Punjab.
  • To identify specific areas of deficiency in understanding HCV transmission, presentation, complications, and treatment.

Main Methods:

  • A questionnaire was mailed to 936 randomly selected family physicians across 7 districts in Punjab.
  • The questionnaire assessed knowledge on HCV transmission, clinical aspects, complications, treatment, and common medical practices.
  • Physicians' responses were collected anonymously.

Main Results:

  • A low response rate of 28% (262 physicians) was observed.
  • While 76% knew HCV is parenterally transmitted, 18% admitted to reusing needles/syringes.
  • Only 58% recognized HCV as a common cause of acute viral hepatitis, and 72% knew diagnostic tests.

Conclusions:

  • A significant proportion of family physicians in Punjab demonstrate knowledge gaps regarding HCV.
  • Despite awareness of parenteral transmission, unsafe practices like needle reuse persist.
  • Enhanced education and awareness programs are crucial for improving HCV management by primary care physicians.
Abstract

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...